Sclerosing angiomatoid nodular transformation of the spleen: A case report and literature review

Shu-Xuan Li, Ye-Hui Fan, Hao Wu, Guo-Yue Lv

Shu-Xuan Li, Hao Wu, Guo-Yue Lv, Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University, Changchun 130021, Jilin Province, China

Ye-Hui Fan, Department of The First Operation Room, First Hospital of Jilin University,Changchun 130021, Jilin Province, China

Abstract BACKGROUND Sclerosing angiomatoid nodular transformation (SANT) is a rare disease of the spleen. It has unique pathological features and mimics splenic tumor on radiological imaging.CASE SUMMARY A 47-year-old woman was incidentally found to have a splenic mass on abdominal ultrasound. She had a 10-cm postoperative scar in the lower abdomen due to previous cesarean sections. The patient had a past history of anemia of unknown etiology for 20 years. The patient underwent laparoscopic splenectomy.The postoperative course was uneventful, with a hospital stay of 7 d. The histopathological examination of the spleen revealed SANT. At the 6-mo followup, the patient remained disease-free.CONCLUSION SANT is a rare benign disease mimicking a malignant tumor. A definitive diagnosis can be made only on histopathology.

Key Words: Splenic neoplasms; Sclerosing angiomatoid nodular transformation; Spleen;Case report

INTRODUCTION

Sclerosing angiomatoid nodular transformation (SANT) of the spleen is a rare benign lesion[1]. SANT was first reported and described as a benign splenic lesion by Martelet al[1]. SANT is more common in women than men and has no characteristic clinical or radiological features. Most patients undergo open or laparoscopic splenectomy due to a diagnostic dilemma. The final diagnosis is made based on histopathological examination of the spleen. We report a case of SANT and discuss the radiological and immunohistochemical characteristics of this disease.

CASE PRESENTATION

Chief complaints

A 47-year-old woman visited our hospital for a yearly health checkup.

History of present illness

She denied any recent fever, allergy, chills, or changes in bowel habits.

History of past illness

The patient had a past history of anemia of unknown etiology for 20 years. She also had a history of cesarean sections performed 23 years earlier.

Personal and family history

She did not have any addictions or any significant family history.

Physical examination

On clinical examination, there was a 10-cm postoperative scar in the lower abdomen due to previous cesarean sections. The abdominal examination was unremarkable with no organomegaly.

Laboratory examinations

Laboratory testing revealed a hemoglobin level of 85 g/L (normal, 115–150 g/L)suggestive of moderate anemia. The white blood cell and platelet counts were normal.The following tumor markers were within the normal range: serum carcinoembryonic antigen (0.58 ng/mL, normal < 5.0 ng/mL); cancer antigen (CA) 125 (9.46 U/mL,normal < 35 U/mL); alpha fetoprotein (5.38 ng/mL, normal < 20 ng/mL); and CA19-9(5.97 U/mL, normal < 37 U/mL). The coagulation profile and liver function tests were within normal limits.

To determine the cause of the anemia, the patient underwent a bone marrow biopsy and smear examination, which revealed iron deficiency anemia.

Imaging examinations

On abdominal ultrasound, a splenic lesion 5.9 cm × 5.1 cm in size and hypoechoic in nature was found at the upper pole of the spleen. A computed tomography (CT) scan showed a hypodense solid lesion, 5.9 cm × 5.1 cm, located at the upper pole of the spleen in the non-contrast phase (Figure 1A) and mild progressive enhancement in the contrast-enhanced phase (Figure 1B).

FINAL DIAGNOSIS

A final diagnosis of splenic tumor was made.

TREATMENT

With a provisional diagnosis of splenic tumor, the patient was scheduled for laparoscopic splenectomy. The patient and her relatives were informed about the increased risk of overwhelming post-splenectomy infection (OPSI) after splenectomy.They were also informed about the need for an intraoperative histopathological examination of the spleen, and if the tumor was benign, a spleen autotransplantation would be considered[2]. However, due to the possibility of missing a malignancy on intraoperative histopathological examination and the low risk of OPSI in adults, the patient and her family members insisted on splenectomy and declined an intraoperative histopathological examination.

During the operation, a mass lesion measuring 7 cm × 5.5 cm × 5 cm was found at the upper pole of the spleen. Laparoscopic splenectomy was performed and the resected spleen was sent for histological examination. The operative time was 85 min,and estimated blood loss was 60 mL. The postoperative course was uneventful, with a hospital stay of 7 d.

On macroscopic examination, the splenic lesion was well encapsulated, off-white and dull-red in color, and firm in consistency (Figure 2). On microscopic examination,there were multiple rounded hemangiomatous nodules surrounded by fibrosclerotic stroma (Figure 3). Immunohistochemistry revealed the following findings (Figure 4):cluster of differentiation (CD) 31 (+), CD34 (+), CD68 (+), Ki67 (1%), and smoothmuscle actin (SMA) (+). Based on these findings, a pathological diagnosis of SANT was made.

OUTCOME AND FOLLOW-UP

At the 6-mo follow-up, the patient remained disease-free and her anemia had resolved.

DISCUSSION

SANT is a rare benign lesion of the spleen. It was initially named multinodular hemangioma by Rosaiet al[3]. In 2004, Martelet al[1]coined the term SANT for the first time. Based on their study of 25 cases, the authors concluded that SANT is a benign vascular lesion of the spleen probably caused by a reactive process.

The exact pathogenesis of SANT is unknown. Some researchers have detected Epstein-Barr virus RNA in resected specimens, suggesting that its pathogenesis could be similar to that of inflammatory pseudotumors[4]. Other studies have found a large number of IgG4-positive plasma cells in SANT samples, suggesting that SANT may be associated with IgG4-related autoimmune diseases[5].

SANT occurs more frequently in women than men. It is most often asymptomatic and has no characteristic clinical features (Table 1). The most common complaint is abdominal pain. In our case, the patient was asymptomatic. Laboratory tests may show an elevated erythrocyte sedimentation rate, leukocytosis, and thrombocytopenia[1].

The most common imaging methods used for SANT are CT and magnetic resonance imaging of the abdomen (Table 2). In most of the reported cases, SANT presents as a solitary lesion but can be multifocal in rare cases. However, none of the radiological features are pathognomonic of SANT, and further studies are required to differentiate SANT from malignant lesions of the spleen. Ramanet al[6]noted that it is difficult to differentiate SANT from other splenic diseases by radiological imaging alone. The final diagnosis is mainly based on histopathological and immunohistochemical examination of the resected specimen. The differential diagnosis of SANT includeshemangioma, splenic hamartoma, angiosarcoma, hemangioendothelioma, and inflammatory pseudotumor.

Table 1 Clinical features of sclerosing angiomatoid nodular transformation reported in the literature

Table 2 Radiological characteristics of sclerosing angiomatoid nodular transformation reported in the literature

On histological examination with hematoxylin and eosin staining, multiple hemangioma-like nodules, fissure-like or sinus-like vascular cavities are visible in the center of the nodules, with a small number of tissue cells scattered around the lacunae,and a dense concentric distribution of smooth muscle or collagen fibers around the nodules. On immunohistochemical staining, three types of vascular structures are seen in SANT nodules: A capillary network, sinusoid vascular spaces, and small venous vessels. The cells of all three structures are CD31-positive. Moreover, the cells of the capillary network are CD34-positive while the cells of the sinusoid vascular spaces are CD8-positive[1,7]. In addition, there are spindle cells around the nodules that are positive for CD68, SMA, and vimentin. The cell proliferation (Ki-67) index is usually <5%[7,8].

SANT of the spleen is a benign disease that does not require surgery unless the patient is symptomatic. However, due to diagnostic dilemma, most patients undergo splenectomy to rule out malignancy or another pathological disease of the spleen[9]. In our case, the patient underwent laparoscopic splenectomy and recovered without complications. At the 6-mo follow-up, the patient was free of disease.

Figure 1 Computed tomography of the abdomen showing the hypodense splenic lesion on non-contrast and contrast-enhanced images.A: Non-contrast phase of computed tomography showed a hypodense solid lesion, 5.9 cm × 5.1 cm, located at the upper pole of the spleen; B: Contrast-enhanced image showed a mild progressive enhancement of the lesion.

Figure 2 Cut section of the spleen showing well encapsulated splenic lesion, off-white and dull-red in color, and firm in consistency.

Figure 3 Microscopic appearance of the splenic lesion showing multiple rounded hemangiomatous nodules surrounded by fibrosclerotic stroma (hematoxylin and eosin, 100 ×).

CONCLUSION

SANT is a rare benign disease of the spleen that mimics malignant tumors on radiological imaging. Clinical differentiation between SANT and other splenic diseases is difficult. Splenectomy is both diagnostic and therapeutic in symptomatic cases. A definitive diagnosis can be made only with histopathological and immunohistochemical examination of the resected spleen.

Figure 4 Immunohistochemical analysis showed positive staining of the splenic tumor tissues for the following stains. A: CD31, B: CD34, C:CD68, D: Smooth-muscle actin.